Cardinal Health (CAH) 77.56 $CAH Watch for Card
Post# of 273330
Posted On: 09/23/2016 7:15:06 AM
Cardinal Health (CAH) 77.56 $CAH
Watch for Cardinal Health to Potentially Pullback After Gaining 1.16% Yesterday
Comtex SmarTrend(R) - Thu Sep 22, 2:10PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.14 to a high of $77.75. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.63 on volume of 989,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 77.56 (+0.71)
SmarTrend Watching for Potential Pullback in Shares of Cardinal Health After 1.16% Gain
Comtex SmarTrend(R) - Thu Sep 22, 2:09PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.14 to a high of $77.75. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.63 on volume of 989,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 77.56 (+0.71)
Navidea Achieves $1 Million in Lymphoseek(R) Commercial Milestones
BusinessWire - Thu Sep 22, 5:59AM CDT
--- Navidea to receive $500,000 payment from SpePharm AG, an affiliate of Norgine, B.V., for EMA approval of Lymphoseek single dose vial -
NAVB: 0.99 (+0.01), CAH: 77.56 (+0.71)
SmarTrend Watching for Potential Rebound in Shares of Cardinal Health After 2.97% Loss
Comtex SmarTrend(R) - Wed Sep 14, 12:03PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $75.33 to a high of $78.07. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $77.63 on volume of 3.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CAH: 77.56 (+0.71)
Cardinal Health (CAH) Breaks Through Support at $77.37
Comtex SmarTrend(R) - Wed Sep 14, 9:09AM CDT
Cardinal Health (NYSE:CAH) has opened bearishly below the pivot of $78.35 today and has reached the first level of support at $77.37. Should the shares continue to fall, the support pivots of $76.66 and $74.97 will be of interest.
CAH: 77.56 (+0.71)
Navidea Biopharmaceuticals to Hold Investor Update Call
BusinessWire - Tue Sep 06, 2:21PM CDT
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) announced that the Company will hold an audio webcast conference call on Wednesday, September 7, 2016 at 8:30 a.m. ET to discuss today's announcement regarding the Letter of Intent for the sale of Lymphoseek in North America to Cardinal Health, Inc.
NAVB: 0.99 (+0.01), CAH: 77.56 (+0.71)
Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of Lymphoseek(R) in North America
BusinessWire - Tue Sep 06, 5:59AM CDT
Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) today announced that it has executed a Letter of Intent ("LOI"
with Cardinal Health, Inc. (NYSE:CAH) for the sale of all rights, title and interest to Navidea's Lymphoseek product for all FDA-approved, pending and future oncology diagnostic indications in North America, subject to certain limitations, as well as certain other related assets. Under the terms of the LOI, Navidea would receive $80 million at closing, with future consideration tied to annual sales of the Lymphoseek product and certain sales-based milestones. Total consideration to Navidea would be capped at $310 million.
NAVB: 0.99 (+0.01), CAH: 77.56 (+0.71)
Fighting Prescription Drug Misuse through Community Programs: Cardinal Health Foundation Announces Generation Rx Medication Disposal Grants
PR Newswire - Wed Aug 31, 8:00AM CDT
Non-profit organizations across the country were awarded grants from the Cardinal Health Foundation to help fight prescription drug misuse by improving their communities' medication disposal programs.
CAH: 77.56 (+0.71)
Akers Biosciences OxiCheck Study Results Positive, Stock Up
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:21AM CDT
Akers Biosciences Inc. (AKER) recently announced favorable clinical results for its BreathScan OxiCheck disposable breath test.
CAH: 77.56 (+0.71), QDEL: 22.79 (+0.91), AKER: 3.23 (-0.11), NUVA: 68.06 (+1.06)
Splunk Enterprise Chosen as Analytics Platform for New IT Architecture at Cardinal Health
BusinessWire - Tue Aug 16, 7:00AM CDT
Splunk Inc. (NASDAQ:SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced that Cardinal Health, a global health services and products company, is standardizing on Splunk(R) Enterprise to monitor the success of a major business infrastructure project. As part of its expanded use, Splunk Enterprise will be the data analytics platform to monitor and analyze IT and business data as Cardinal Health rolls out a new IT architecture. Splunk users at Cardinal Health will be able to gain insights into the health and key performance indicators (KPIs) of the company's IT services and crucial customer-facing applications.
CAH: 77.56 (+0.71), SPLK: 59.13 (-0.08)
Top 3 Research Reports for August 8, 2016
Sheraz Mian - Zacks Investment Research - Mon Aug 08, 11:27AM CDT
Top 3 Research Reports for August 8, 2016
CAH: 77.56 (+0.71), TROW: 66.82 (-0.01), KHC: 89.05 (+1.14), BAC: 15.60 (-0.05), AET: 116.93 (+0.24), MA: 102.12 (+0.86)
Cardinal Health Board of Directors Approves Quarterly Dividend
PR Newswire - Mon Aug 08, 7:30AM CDT
Cardinal Health announced that its board of directors approved a quarterly dividend of $0.4489 per share. This quarterly dividend will be payable on Oct. 15 to shareholders of record at the close of business on Oct. 3.
CAH: 77.56 (+0.71)
The Conference Board Elects New Vice Chair
PR Newswire - Fri Aug 05, 9:00AM CDT
George S. Barrett, Chairman and CEO of Cardinal Health, Inc., has been elected a vice chair of the board of trustees of The Conference Board, the global business membership and research organization, which is celebrating its centennial this year. Mr. Barrett joined the board as a trustee in 2010.
CAH: 77.56 (+0.71)
Company News for August 03, 2016
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 9:10AM CDT
Companies in the News are: ABC,ADM,AVP,CAH
ABC: 83.59 (+0.57), AVP: 5.74 (+0.10), ADM: 42.98 (+0.17), CAH: 77.56 (+0.71)
Cardinal Health (CAH) Tops Q4 Earnings, '17 View Impressive
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:59PM CDT
Cardinal Health Inc. (CAH) reported fourth-quarter fiscal 2016 adjusted earnings of $1.14 per share, which beat the Zacks Consensus Estimate by a penny.
BCR: 231.35 (+2.84), ALGN: 95.67 (+0.33), CAH: 77.56 (+0.71), MMSI: 24.28 (+0.08)
Cardinal Health Rises 3.15% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Aug 02, 12:35PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $82.01 to a high of $85.52. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $83.89 on volume of 2.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 77.56 (+0.71)
Cardinal Health (CAH) Tops Q4 Earnings on Strong Revenues
Aniruddha Ganguly - Zacks Investment Research - Tue Aug 02, 7:32AM CDT
Cardinal Health???s adjusted earnings of $1.14 per share managed to outpace the Zacks Consensus Estimate of $1.13.
CAH: 77.56 (+0.71)
Watch for Cardinal Health to Potentially Pullback After Gaining 1.16% Yesterday
Comtex SmarTrend(R) - Thu Sep 22, 2:10PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.14 to a high of $77.75. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.63 on volume of 989,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 77.56 (+0.71)
SmarTrend Watching for Potential Pullback in Shares of Cardinal Health After 1.16% Gain
Comtex SmarTrend(R) - Thu Sep 22, 2:09PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.14 to a high of $77.75. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.63 on volume of 989,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 77.56 (+0.71)
Navidea Achieves $1 Million in Lymphoseek(R) Commercial Milestones
BusinessWire - Thu Sep 22, 5:59AM CDT
--- Navidea to receive $500,000 payment from SpePharm AG, an affiliate of Norgine, B.V., for EMA approval of Lymphoseek single dose vial -
NAVB: 0.99 (+0.01), CAH: 77.56 (+0.71)
SmarTrend Watching for Potential Rebound in Shares of Cardinal Health After 2.97% Loss
Comtex SmarTrend(R) - Wed Sep 14, 12:03PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $75.33 to a high of $78.07. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $77.63 on volume of 3.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CAH: 77.56 (+0.71)
Cardinal Health (CAH) Breaks Through Support at $77.37
Comtex SmarTrend(R) - Wed Sep 14, 9:09AM CDT
Cardinal Health (NYSE:CAH) has opened bearishly below the pivot of $78.35 today and has reached the first level of support at $77.37. Should the shares continue to fall, the support pivots of $76.66 and $74.97 will be of interest.
CAH: 77.56 (+0.71)
Navidea Biopharmaceuticals to Hold Investor Update Call
BusinessWire - Tue Sep 06, 2:21PM CDT
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) announced that the Company will hold an audio webcast conference call on Wednesday, September 7, 2016 at 8:30 a.m. ET to discuss today's announcement regarding the Letter of Intent for the sale of Lymphoseek in North America to Cardinal Health, Inc.
NAVB: 0.99 (+0.01), CAH: 77.56 (+0.71)
Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of Lymphoseek(R) in North America
BusinessWire - Tue Sep 06, 5:59AM CDT
Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) today announced that it has executed a Letter of Intent ("LOI"
with Cardinal Health, Inc. (NYSE:CAH) for the sale of all rights, title and interest to Navidea's Lymphoseek product for all FDA-approved, pending and future oncology diagnostic indications in North America, subject to certain limitations, as well as certain other related assets. Under the terms of the LOI, Navidea would receive $80 million at closing, with future consideration tied to annual sales of the Lymphoseek product and certain sales-based milestones. Total consideration to Navidea would be capped at $310 million. NAVB: 0.99 (+0.01), CAH: 77.56 (+0.71)
Fighting Prescription Drug Misuse through Community Programs: Cardinal Health Foundation Announces Generation Rx Medication Disposal Grants
PR Newswire - Wed Aug 31, 8:00AM CDT
Non-profit organizations across the country were awarded grants from the Cardinal Health Foundation to help fight prescription drug misuse by improving their communities' medication disposal programs.
CAH: 77.56 (+0.71)
Akers Biosciences OxiCheck Study Results Positive, Stock Up
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:21AM CDT
Akers Biosciences Inc. (AKER) recently announced favorable clinical results for its BreathScan OxiCheck disposable breath test.
CAH: 77.56 (+0.71), QDEL: 22.79 (+0.91), AKER: 3.23 (-0.11), NUVA: 68.06 (+1.06)
Splunk Enterprise Chosen as Analytics Platform for New IT Architecture at Cardinal Health
BusinessWire - Tue Aug 16, 7:00AM CDT
Splunk Inc. (NASDAQ:SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced that Cardinal Health, a global health services and products company, is standardizing on Splunk(R) Enterprise to monitor the success of a major business infrastructure project. As part of its expanded use, Splunk Enterprise will be the data analytics platform to monitor and analyze IT and business data as Cardinal Health rolls out a new IT architecture. Splunk users at Cardinal Health will be able to gain insights into the health and key performance indicators (KPIs) of the company's IT services and crucial customer-facing applications.
CAH: 77.56 (+0.71), SPLK: 59.13 (-0.08)
Top 3 Research Reports for August 8, 2016
Sheraz Mian - Zacks Investment Research - Mon Aug 08, 11:27AM CDT
Top 3 Research Reports for August 8, 2016
CAH: 77.56 (+0.71), TROW: 66.82 (-0.01), KHC: 89.05 (+1.14), BAC: 15.60 (-0.05), AET: 116.93 (+0.24), MA: 102.12 (+0.86)
Cardinal Health Board of Directors Approves Quarterly Dividend
PR Newswire - Mon Aug 08, 7:30AM CDT
Cardinal Health announced that its board of directors approved a quarterly dividend of $0.4489 per share. This quarterly dividend will be payable on Oct. 15 to shareholders of record at the close of business on Oct. 3.
CAH: 77.56 (+0.71)
The Conference Board Elects New Vice Chair
PR Newswire - Fri Aug 05, 9:00AM CDT
George S. Barrett, Chairman and CEO of Cardinal Health, Inc., has been elected a vice chair of the board of trustees of The Conference Board, the global business membership and research organization, which is celebrating its centennial this year. Mr. Barrett joined the board as a trustee in 2010.
CAH: 77.56 (+0.71)
Company News for August 03, 2016
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 9:10AM CDT
Companies in the News are: ABC,ADM,AVP,CAH
ABC: 83.59 (+0.57), AVP: 5.74 (+0.10), ADM: 42.98 (+0.17), CAH: 77.56 (+0.71)
Cardinal Health (CAH) Tops Q4 Earnings, '17 View Impressive
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:59PM CDT
Cardinal Health Inc. (CAH) reported fourth-quarter fiscal 2016 adjusted earnings of $1.14 per share, which beat the Zacks Consensus Estimate by a penny.
BCR: 231.35 (+2.84), ALGN: 95.67 (+0.33), CAH: 77.56 (+0.71), MMSI: 24.28 (+0.08)
Cardinal Health Rises 3.15% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Aug 02, 12:35PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $82.01 to a high of $85.52. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $83.89 on volume of 2.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 77.56 (+0.71)
Cardinal Health (CAH) Tops Q4 Earnings on Strong Revenues
Aniruddha Ganguly - Zacks Investment Research - Tue Aug 02, 7:32AM CDT
Cardinal Health???s adjusted earnings of $1.14 per share managed to outpace the Zacks Consensus Estimate of $1.13.
CAH: 77.56 (+0.71)
(0)
(0)